Results 81 to 90 of about 13,217 (287)

Assessing the ability of large language models to summarize and generate maxillofacial prosthetic treatment options

open access: yesJournal of Prosthodontics, EarlyView.
Abstract Purpose The aim was to evaluate the ability of four large language models (LLMs) (OpenAI's ChatGPT‐3.5, Microsoft 365 Copilot, DeepSeek‐R1, and Google Gemini 2.5 Pro) to develop treatment options when presented with clinical cases published in the maxillofacial prosthodontics literature.
Leila M. Sears   +10 more
wiley   +1 more source

The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study.

open access: yesBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2020
OBJECTIVES Medication-related osteonecrosis of the jaw (MRONJ) is defined as exposed bone in the maxillofacial region persisting for more than eight weeks in patients who are or were treated with antiresorptive or antiangiogenic agents and had no ...
J. Zelinka   +5 more
semanticscholar   +1 more source

Comparative survival analysis of endodontic re‐treatment and single‐tooth implants: A retrospective cohort study using shared frailty modeling

open access: yesJournal of Prosthodontics, EarlyView.
Abstract Purpose To compare the long‐term survival of nonsurgical endodontic re‐treatment versus single‐tooth implants and to identify independent demographic, systemic, and lifestyle predictors of failure using a statistical model that accounts for patient‐level clustering.
Georgios S. Chatzopoulos, Larry F. Wolff
wiley   +1 more source

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.

open access: yesBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2020
BACKGROUND Medication - related osteonecrosis of the jaw (MRONJ) is a rare but serious complication of antiresorptive and/or antiangiogenic therapy. It mainly affects oncological patients, however, it can occur in patients with metabolic bone diseases ...
L. Hauer   +6 more
semanticscholar   +1 more source

Biphosphonates-related osteonecrosis of the jaw

open access: yes, 2019
The relationship between osteonecrosis of the jaw and bisphosphonate therapy has been describedrecently. Although bisphosphonates have a long list of benefits in the treatment of patients with bonemetastases, an increasing number of reports describe the ...
Białożyk-Mularska, Katarzyna; Department of Oncology, Radiotherapy and Gynecologic Oncology, Collegium Medicum, Nicolaus Copernicus University, 85-796 Bydgoszcz, Poland   +1 more
core   +1 more source

Bisphosphonate-associated osteonecrosis can hide jaw metastases. [PDF]

open access: yes, 2007
BACKGROUND: Osteonecrosis of the jaw is a well known potential complication of bisphosphonate treatment but its pathogenesis is poorly understood. The current management of patients with bisphosphonate-associated osteonecrosis (BON) is based on "expert ...
RAGAZZO M.   +19 more
core   +2 more sources

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Sabine Elisabeth Groeger   +5 more
wiley   +1 more source

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw

open access: yesBiomedical Papers, 2015
Aim: This article covers the authors' experience with the treatment of bisphosphonate-related osteonecrosis of the jaw in 11 individuals. Methods: A retrospective study of patients diagnosed and treated for bisphosphonate-related osteonecrosis of the jaw
Zuzana Janovska   +2 more
doaj   +1 more source

Regenerative effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)

open access: yesJournal of the Korean Association of Oral and Maxillofacial Surgeons, 2020
Objectives Beyond the original application approved by the U.S. Food and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) treatment because of its bone ...
Song-Hee Min   +3 more
semanticscholar   +1 more source

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw

open access: yesOral and Maxillofacial Surgery Cases, 2020
We present a unique case of bacterial encephalitis in a 79-year-old female due to progression of medication-related osteonecrosis of the jaw. The occurrence of this life-threatening neurologic condition following the expansion of medication-related ...
Hye-Won Kim   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy